NEUROPACE, INC. Proceeds from Sale of Short-term Investments
NEUROPACE, INC. (NPCE) reported Proceeds from Sale of Short-term Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfShortTermInvestments · last filed 2026-03-03
- NEUROPACE, INC. proceeds from sale of short-term investments for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. proceeds from sale of short-term investments for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. proceeds from sale of short-term investments for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. proceeds from sale of short-term investments for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. proceeds from sale of short-term investments for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- NEUROPACE, INC. proceeds from sale of short-term investments for fiscal 2024 was $9.30M, a 59.91% decline from fiscal 2023.
- NEUROPACE, INC. proceeds from sale of short-term investments for fiscal 2023 was $23.20M, a 4.92% decline from fiscal 2022.
- NEUROPACE, INC. proceeds from sale of short-term investments for fiscal 2022 was $24.40M.
| Period end | Proceeds from Sale of Short-term Investments 3 month | Proceeds from Sale of Short-term Investments 6 month | Proceeds from Sale of Short-term Investments 9 month | Proceeds from Sale of Short-term Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $0.00 derived: sum of 3 quarters · filed 2026-03-03 | $0.00 10-K · filed 2026-03-03 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | $2.00M derived: sum of 4 quarters · filed 2026-03-03 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $2.00M derived: sum of 3 quarters · filed 2026-03-03 | $3.50M derived: sum of 4 quarters · filed 2026-03-03 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | $2.00M derived: sum of 2 quarters · filed 2026-03-03 | $3.50M derived: sum of 3 quarters · filed 2026-03-03 | $6.80M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.50M derived: sum of 2 quarters · filed 2026-03-03 | $6.80M derived: sum of 3 quarters · filed 2026-03-03 | $9.30M 10-K · filed 2026-03-03 |
| 2024-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.80M derived: sum of 2 quarters · filed 2025-11-04 | $7.30M 10-Q · filed 2025-11-04 | $10.80M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $5.80M 10-Q · filed 2025-08-12 | $9.30M derived: sum of 3 quarters · filed 2025-08-12 | $13.50M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $2.50M 10-Q · filed 2025-05-13 | $6.00M derived: sum of 2 quarters · filed 2025-05-13 | $10.20M derived: sum of 3 quarters · filed 2025-05-13 | $15.50M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $7.70M derived: sum of 2 quarters · filed 2025-03-04 | $13.00M derived: sum of 3 quarters · filed 2025-03-04 | $23.20M 10-K · filed 2025-03-04 |
| 2023-09-30 | $4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $9.50M derived: sum of 2 quarters · filed 2024-11-12 | $19.70M 10-Q · filed 2024-11-12 | $28.70M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $5.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $15.50M 10-Q · filed 2024-08-13 | $24.50M derived: sum of 3 quarters · filed 2024-08-13 | $31.50M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $10.20M 10-Q · filed 2024-05-08 | $19.20M derived: sum of 2 quarters · filed 2024-05-08 | $26.20M derived: sum of 3 quarters · filed 2024-05-08 | $34.60M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $16.00M derived: sum of 2 quarters · filed 2024-03-05 | $24.40M derived: sum of 3 quarters · filed 2024-03-05 | $24.40M 10-K · filed 2024-03-05 |
| 2022-09-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $15.40M derived: sum of 2 quarters · filed 2023-11-06 | $15.40M 10-Q · filed 2023-11-06 | $15.40M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $8.40M 10-Q · filed 2023-08-08 | $8.40M derived: sum of 3 quarters · filed 2023-08-08 | $8.40M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-05-04 | $0.00 derived: sum of 3 quarters · filed 2023-05-04 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | $6.30M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |